Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in African Americ...

Descripción completa

Detalles Bibliográficos
Autores principales: A. Romero, Cesar, Mathew, Shobi, Wasinski, Benjamin, Reed, Brian, Brody, Aaron, Dawood, Rachelle, Twiner, Michael J., McNaughton, Candace D., Fridman, Rafael, Flack, John M., Carretero, Oscar A., Levy, Phillip D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Anti‐fibrotic Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678784/
https://www.ncbi.nlm.nih.gov/pubmed/33694311
http://dx.doi.org/10.1111/jch.14206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678784/
https://www.ncbi.nlm.nih.gov/pubmed/33694311
http://dx.doi.org/10.1111/jch.14206

Ejemplares similares